These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
546 related items for PubMed ID: 14581420
1. Time course and predictors of symptoms after primary prostate cancer therapy. Talcott JA, Manola J, Clark JA, Kaplan I, Beard CJ, Mitchell SP, Chen RC, O'Leary MP, Kantoff PW, D'Amico AV. J Clin Oncol; 2003 Nov 01; 21(21):3979-86. PubMed ID: 14581420 [Abstract] [Full Text] [Related]
2. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC. J Natl Cancer Inst; 2004 Sep 15; 96(18):1358-67. PubMed ID: 15367568 [Abstract] [Full Text] [Related]
3. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. Miller DC, Sanda MG, Dunn RL, Montie JE, Pimentel H, Sandler HM, McLaughlin WP, Wei JT. J Clin Oncol; 2005 Apr 20; 23(12):2772-80. PubMed ID: 15837992 [Abstract] [Full Text] [Related]
4. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. Gore JL, Kwan L, Lee SP, Reiter RE, Litwin MS. J Natl Cancer Inst; 2009 Jun 16; 101(12):888-92. PubMed ID: 19509365 [Abstract] [Full Text] [Related]
5. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Ferrer M, Suárez JF, Guedea F, Fernández P, Macías V, Mariño A, Hervas A, Herruzo I, Ortiz MJ, Villavicencio H, Craven-Bratle J, Garin O, Aguiló F, Multicentric Spanish Group of Clinically Localized Prostate Cancer. Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):421-32. PubMed ID: 18325680 [Abstract] [Full Text] [Related]
6. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer. Bradley EB, Bissonette EA, Theodorescu D. BJU Int; 2004 Nov 01; 94(7):1003-9. PubMed ID: 15541117 [Abstract] [Full Text] [Related]
7. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy. Hedgepeth RC, Labo J, Zhang L, Wood DP. J Urol; 2009 Jul 01; 182(1):221-7; discussion 227-8. PubMed ID: 19450842 [Abstract] [Full Text] [Related]
8. Complications from treatment for prostate carcinoma among men in the Detroit area. Schwartz K, Bunner S, Bearer R, Severson RK. Cancer; 2002 Jul 01; 95(1):82-9. PubMed ID: 12115320 [Abstract] [Full Text] [Related]
9. Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment. Pardo Y, Guedea F, Aguiló F, Fernández P, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Craven-Bratle J, Suárez JF, Boladeras A, Pont À, Ayala A, Sancho G, Martínez E, Alonso J, Ferrer M. J Clin Oncol; 2010 Nov 01; 28(31):4687-96. PubMed ID: 20921463 [Abstract] [Full Text] [Related]
10. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up. Ferrer M, Guedea F, Suárez JF, de Paula B, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Sancho G, Boladeras A, Ayala A, Craven-Bratle J, Ávila M, Cunillera O, Pardo Y, Alonso J, Aguiló F, Clinically Localized Prostate Cancer. Radiother Oncol; 2013 Aug 01; 108(2):306-13. PubMed ID: 23849168 [Abstract] [Full Text] [Related]
11. Patients' perceptions of quality of life after treatment for early prostate cancer. Clark JA, Inui TS, Silliman RA, Bokhour BG, Krasnow SH, Robinson RA, Spaulding M, Talcott JA. J Clin Oncol; 2003 Oct 15; 21(20):3777-84. PubMed ID: 14551296 [Abstract] [Full Text] [Related]
12. Quality of life outcomes after brachytherapy for early stage prostate cancer. Brandeis JM, Litwin MS, Burnison CM, Reiter RE. J Urol; 2000 Mar 15; 163(3):851-7. PubMed ID: 10687991 [Abstract] [Full Text] [Related]
13. Defining sexual outcomes after treatment for localized prostate carcinoma. Schover LR, Fouladi RT, Warneke CL, Neese L, Klein EA, Zippe C, Kupelian PA. Cancer; 2002 Oct 15; 95(8):1773-85. PubMed ID: 12365027 [Abstract] [Full Text] [Related]
14. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy. Glickman L, Godoy G, Lepor H. J Urol; 2009 Feb 15; 181(2):731-5. PubMed ID: 19091349 [Abstract] [Full Text] [Related]
15. Treatment 'mismatch' in early prostate cancer: do treatment choices take patient quality of life into account? Chen RC, Clark JA, Manola J, Talcott JA. Cancer; 2008 Jan 01; 112(1):61-8. PubMed ID: 18040996 [Abstract] [Full Text] [Related]
16. 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, Hamilton A, Hoffman RM, Stephenson RA, Potosky AL, Stanford JL. J Urol; 2005 May 01; 173(5):1701-5. PubMed ID: 15821561 [Abstract] [Full Text] [Related]